Search Results - "Maslennikov, V. N."

Target determination for transcranial magnetic stimulation in patients with a pharmacotherapy-resistant depressive episode based on the individual parameters of resting-state functional magnetic resonance imaging (a pilot blind controlled trial) by Poydasheva, A. G., Sinitsyn, D. O., Bakulin, I. S., Suponeva, N. A., Maslennikov, N. V., Tsukarzi, E. E., Mosolov, S. N., Piradov, M. A.

“…High-frequency repetitive transcranial magnetic stimulation (rTMS) is approved by the Food and Drug Administration (FDA) for the treatment of…”
Get full text

Method for measuring the insertion loss of ultrasonic delay lines by Vizen, F. L., Maslennikov, V. N.

Get full text

Abstracts by Aboyan, A. O., iramdzhyan, F. O., Bezirganyan, P. A., Kolesov, S. N., Kil'deev, I. A., Kolesov, I. S., Balaban, N. B., Maslennikov, V. N., Gershanov, V. Yu, Kireev, E. I., Lozovskii, V. N., Shcherinskii, V. L., Savel'ev, G. G., Eroshkin, V. I., Mal'chenko, S. N., Klykov, I. I., Popova, T. N.

Get full text